These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1148499)

  • 41. Release and inhibition of uptake of 5-hydroxytryptamine in blood platelets in vitro by copper and methyl mercury.
    Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):292-7. PubMed ID: 6869022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.
    Gordon JL; Olverman HJ
    Br J Pharmacol; 1978 Feb; 62(2):219-26. PubMed ID: 623937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New evidence for a loss of serotonergic nerve terminals in rats treated with d,l-fenfluramine.
    Westphalen RI; Dodd PR
    Pharmacol Toxicol; 1993; 72(4-5):249-55. PubMed ID: 8372042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.
    Heal DJ; Cheetham SC; Prow MR; Martin KF; Buckett WR
    Br J Pharmacol; 1998 Sep; 125(2):301-8. PubMed ID: 9786502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The uptake of tyramine by rat platelets.
    Bianchi L; Stella L; Dagnino G; de Gaetano G; Rossi EC
    Biochem Pharmacol; 1981 Apr; 30(7):709-13. PubMed ID: 7247954
    [No Abstract]   [Full Text] [Related]  

  • 47. Release of (14C)5-hydroxytryptamine from human platelets by red wine.
    Jarman J; Glover V; Sandler M
    Life Sci; 1991; 48(24):2297-300. PubMed ID: 2046460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of cadmium treatment in vitro on the uptake and release of [3H]serotonin by human blood platelets.
    Mukhopadhyay S; Mukhopadhyay S; Addya S; Bhattacharya DK; Chatterjee GC
    Indian J Biochem Biophys; 1989 Feb; 26(1):56-60. PubMed ID: 2777314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of organotins on rat platelets.
    Johnson TL; Knowles CO
    Toxicology; 1983 Dec; 29(1-2):39-48. PubMed ID: 6658800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of protriptyline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma.
    Trenchard A; Turner P; Pare CM; Hills M
    Psychopharmacologia; 1975 Jul; 43(1):89-93. PubMed ID: 1161997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double action of nicardipine on serotonin release from rat platelets.
    Baudouin-Legros M; Dard B; Guicheney P; Meyer P
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):287-92. PubMed ID: 2444776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
    Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
    J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake of 5-hydroxytryptamine by rat blood platelets and its inhibition by adenosine 5'-diphosphate.
    Drummond AH; Gordon JL
    Br J Pharmacol; 1976 Apr; 56(4):417-21. PubMed ID: 1260221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Competition between platelets and lung for 5-hydroxytryptamine uptake.
    Steinberg H; Das DK
    Exp Lung Res; 1980 Jun; 1(2):121-30. PubMed ID: 7227342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sphingosine induced release of K+ and 5-HT in platelets should not be confused with membrane leakiness.
    Mäkelä JH; Isomaa B
    Chem Biol Interact; 1992 Nov; 85(1):27-33. PubMed ID: 1458549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of 2,5-dimethoxy-4-methylamphetamine (DOM, STP) on the uptake and release of 14C-5-hydroxytryptamine by rabbit blood platelets.
    Huang JT; Airaksinen MM; Ho BT
    Eur J Pharmacol; 1974 Feb; 25(2):251-4. PubMed ID: 4435028
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibitory effect of ethanol on 5-hydroxytryptamine (serotonin) uptake in human blood platelets in vitro.
    Lingjaerde O
    Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):394-8. PubMed ID: 539436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
    Pietraszek MH; Buczko W
    Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.